Minimally Invasive Robot-B (02252) Fa Yingxi expects mid-term net profit of about 28 million yuan to 40 million yuan to turn a year-on-year loss into profit

Zhitong Finance App News, Minimally Invasive Robot-B (02252) issued an announcement. The board of directors expects the company to change from net loss to record net profit in the six months ending June 30, 2026, and the expected net profit is between RMB 28 million and RMB 40 million, while the company's net loss for the six months ending June 30, 2025 is RMB 115 million. This is the first time that the company has achieved semi-annual profits.

The company turned a loss into a profit during the reporting period, mainly due to the following reasons: 1. Significant increase in operating income - during the reporting period, the Group achieved a year-on-year increase in revenue of about 200% to 230%. Tumai's endoscopic surgical robots are making double efforts in domestic and overseas markets, and the sales scale has expanded significantly. In particular, Tumai's overseas market revenue increased by more than 450% year on year. This growth has benefited from the widespread recognition of the product's technical competitiveness and clinical application performance, and the Group has effectively collaborated with the overseas sales channels and resources of minimally invasive medicine to achieve a simultaneous increase in the depth and breadth of market coverage. 2. Significant improvement in gross margin — During the reporting period, the company's overall gross margin increased by more than 15 percentage points compared to the same period last year. On the one hand, this increase stems from the fixed cost dilution effect brought about by the expansion of production scale; on the other hand, continuous optimization of the production process promotes the effective narrowing of direct labor costs, and the phased implementation of the cost reduction process also helps to gradually reduce material costs; at the same time, the continuous optimization of the product portfolio, especially the rapid growth in high-margin consumables revenue, also drives a steady rise in gross margin. 3. Continuous optimization of cost control - During the reporting period, the company continued to achieve positive results in cost control and resource allocation. The share of operating expenses in operating income decreased markedly, and overall operating efficiency was further improved.

In summary, the combined effects of the three factors of revenue growth, gross margin improvement, and cost control optimization have laid a solid foundation for the Group to achieve profit for the first time in the reporting period.